Valneva SE (VALN) Invested Capital (2020 - 2025)
Valneva SE's (VALN) quarterly Invested Capital came in at $208.6 million in Q4 2025, up 4.18% year-on-year from $200.2 million in Q4 2024, and up 4.18% quarter-over-quarter from $200.2 million in Q4 2024.
Valneva SE (VALN) Invested Capital (2020 - 2025) Analysis & Trends
Valneva SE has disclosed Invested Capital across 6 years of filings, most recently posting $208.6 million for Q4 2025.
- Invested Capital for Q4 2025 came in at $208.6 million, up 4.18% year-over-year; the trailing twelve-month figure through Mar 2026 was $208.6 million (down 5.88% YoY), and the FY2025 annual result was $208.6 million, up 4.18% from the prior year.
- Invested Capital came in at $208.6 million for Q4 2025 at Valneva SE, up from $200.2 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $315.2 million in Q4 2022 to a low of $21.4 million in Q2 2024.
- The 5-year median for Invested Capital is $190.2 million (2023), against an average of $183.0 million.
- Peak annual rise in Invested Capital reached 31.96% in 2023, while the deepest fall reached 42.82% in 2023.
- Valneva SE's Invested Capital stood at $252.0 million in 2021, then advanced by 25.1% to $315.2 million in 2022, then slumped by 42.82% to $180.2 million in 2023, then climbed by 11.09% to $200.2 million in 2024, then gained by 4.18% to $208.6 million in 2025.
- The last three Invested Capital figures came in at $208.6 million (Q4 2025), $200.2 million (Q4 2024), and $21.4 million (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 7.14 Bn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 795.79 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 595,226.00 |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 14.38 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 502.95 Mn |
| 10 | Valneva SE | 167.33 Mn | 44.10 Mn | 5.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 208.60 Mn |
| Dec 31, 2024 | 200.23 Mn |
| Jun 30, 2024 | 21.39 Mn |
| Dec 31, 2023 | 180.24 Mn |
| Mar 31, 2023 | 219.80 Mn |
| Dec 31, 2022 | 315.24 Mn |
| Sep 30, 2022 | 166.35 Mn |
| Jun 30, 2022 | 99.51 Mn |
| Mar 31, 2022 | 166.56 Mn |
| Dec 31, 2021 | 252.00 Mn |
| Dec 31, 2020 | 347.16 Mn |